10 Bladder Cancer Clinical Trials in Rochester, MI (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Bladder Cancer Studies in Rochester

NCT03193970Recruiting

Measuring Surgical Recovery After Radical Cystectomy

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of th...

Rochester, MI2,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT06109857Recruiting

Bladder Bank (a Prospective Banking Study)

This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer....

Rochester, MI1,500 participantsMayo Clinic

View Study Details

NCT06891209Recruiting

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

This study explores and compares health-related quality of life and urinary outcomes in postoperative partial cystectomy and matched radical cystectomy patients....

Rochester, MI1,000 participantsMayo Clinic

View Study Details

NCT03193541Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic h...

Rochester, MI900 participantsCedars-Sinai Medical Center

View Study Details

NCT07029256Recruiting

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB)....

Rochester, MI100 participantsMayo Clinic

View Study Details

NCT05521698Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

This phase I trial evaluates the effects of bicalutamide, compared to no study drug (NSD), on epidermal growth factor receptor (EGFR) protein expression in patients with non-muscle invasive bladder ca...

Rochester, MI80 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06764095Recruiting

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

This phase IV trial tests the impact of standard of care enfortumab vedotin and pembrolizumab followed by removal of all or part of the bladder (cytoreductive cystectomy) and/or removal of all or part...

Rochester, MI75 participantsMayo Clinic

View Study Details

NCT07087860Recruiting

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

This phase II trial compares therapeutic plasma exchange followed by enfortumab vedotin and pembrolizumab to standard of care next-line therapy for the treatment of patients with bladder or upper urin...

Rochester, MI70 participantsMayo Clinic

View Study Details

NCT05868265Recruiting

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

The purpose of this study is to find out whether the study drug, enfortumab vedotin, is an effective and safe treatment for people who have urothelial carcinoma of the upper urinary tract. Study parti...

Rochester, MI24 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06668493Recruiting

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC. To help with this evaluation, a safety lead-in period will be conducte...

Rochester, MI20 participantsFerring Pharmaceuticals

View Study Details

About Bladder Cancer Clinical Trials in Rochester

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 10 bladder cancer clinical trials recruiting participants in Rochester, MI. These studies are seeking a combined 5,769 participants. Research is being sponsored by M.D. Anderson Cancer Center, Mayo Clinic, Cedars-Sinai Medical Center and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Rochester — FAQ

Are there bladder cancer clinical trials in Rochester?

Yes, there are 10 bladder cancer clinical trials currently recruiting in Rochester, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 10 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated July 13, 2026 from ClinicalTrials.gov